In parallel, a decline in EV-CD19+ was observed in B-ALL PB; while, in B-ALL BM, a distinct behavior was observed, with a decrease on D15 followed by an increase on D35 (Figure 3). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.